Andrew T. Hale, PhD is currently a MD candidate at the Vanderbilt University School of Medicine. He is concurrently conducting post-doctoral research in quantitative human genetics and functional genomics with mentor Eric R. Gamazon Ph.D. in the Vanderbilt Genetics Institute and Clare Hall, University of Cambridge (UK). He is using a combination of approaches to understand the genetic architecture of hydrocephalus, cerebrospinal fluid shunt failure, intracerebral aneurysm formation and rupture, epilepsy, and other neurodevelopmental disorders. He received his undergraduate and master’s degrees in biochemistry from Case Western Reserve University where he studied the role of endothelial KLF4 in vascular biology under the guidance of Mukesh K. Jain, MD and Anne Hamik MD, PhD. He earned his PhD under the tutelage of John D. York, PhD, where he applied biochemical, molecular, structural, single-cell sequencing, mouse-model and genetic approaches to study the roles of a family of lithium-sensitive phosphatases in cell-signaling and disease. Andrew is also interested in clinical outcomes research, with a particular emphasis on machine-learning and artificial-intelligence approaches. He plans to pursue a clinical residency in neurological surgery. Beyond work, Andrew enjoys spending time with his wife and two dogs, traveling, and fly fishing.
